Skip to content

Randomized, double-blind, placebo-controlled parallel-group comparative study to investigate the efficacy in probiotics on intestinal environment in healthy subjects

Randomized, double-blind, placebo-controlled parallel-group comparative study to investigate the efficacy in probiotics on intestinal environment in healthy subjects - Clinical study to investigate the efficacy in probiotics on intestinal environment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052110
Enrollment
40
Registered
2023-09-05
Start date
2023-10-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Intake of probiotic yogurt for 17 days Intake of placebo yogurt for 17 days

Sponsors

Matsumoto Health Lab
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subjects of both sexes aged 18 years or older and younger than 65 years.

Exclusion criteria

Exclusion criteria: 1) Individuals who regularly use medicine that affect the gut microbiota such as Intestinal regulators, laxatives, etc. 2) Individuals who cannot stop ingestion of foods and supplements containing lactic acid bacteria, bifidobacteria, oligosaccharides, etc. 3) Individuals who have disease or serious medical history in liver, kidney, heart, lung, gastrointestinal tract, blood, endocrine system, or metabolism, etc. 4) Individuals who have drug allergy, food allergy or medical history. 5) Individuals who have milk allergy or lactose intolerance. 6) Individuals who are pregnant, under lactation or expecting to be pregnant during this study. 7) Individuals who participated in other clinical trials in the past 1 month or who are going to participate in other trials in this study period. 8) Any candidates considered to be inappropriate for this study by the principal investigator based on their background, physical examination, etc.

Design outcomes

Primary

MeasureTime frame
Intestinal environment (gut metabolites, gut microbiota)

Countries

Japan

Contacts

Public ContactKatsuya Furuhata

Matsumoto Health Lab None

info@m-health-lab.jp0263-39-1139

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026